Aquestive reports study results for Anaphylm ahead of NDA resubmission
Go back to Aquestive reports study results for Anaphylm ahead of NDA resubmission| (NASDAQ: AQST) | Delayed: 4.66 -0.16 (3.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.82 | 52 Week High | $ | |||
| Open | $5.00 | 52 Week Low | $ | |||
| Day High | $5.00 | P/E | N/A | |||
| Day Low | $4.62 | EPS | $ | |||
| Volume | 2,529,933 | |||||

